AdvisorShares內幕優勢主動型ETF SURE 深 滬
已收盤 11-06 16:00:00 美东时间
153.5655
-1.443
-0.93%
華盛通- 最 高154.34
- 今 開153.759
- 成交量 720股
- 最 低 153.5655
- 昨 收 155.0089
- 總市值 5835.49万
- 52周最高 158.8954
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 117.904
- 委 比 0.00%
- 總股本 38.00万
- 歷史最高 158.8954
- 量 比 0
- 振 幅 0.50%
- 歷史最低 41.5027
- 每 手 1
- 風險率 10.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SURE前十大重仓股占比12.511%，第一大重仓股为EverQuote, Inc. ORD
数据显示，SURE前十大重仓股合计占基金资产的12.511%。 其中，第一大重仓股为EverQuote, Inc. ORD，持仓占比1.5189%；第二大重仓股...
今天 07:17
Friedman Industries, Incorporated Announces Second Quarter Results
Friedman Industries reported record financial results for the quarter and six months ended September 30, 2026, with net earnings of $15.6 million and $28.4 million, respectively. Sales reached $286.8 million and $526.8 million, up 88% and 83% year-over-year. Sales volume also set records, up 23% and 25% year-over-year. CEO Michael J. Taylor highlighted strong execution, customer demand, and contributions from Century Metals as key drivers. The co...
11-05 21:33
LETTER TO SHAREHOLDERS
Devon Energy has achieved significant milestones since its Coterra combination, including a comprehensive portfolio review, strategic divestitures, and major acquisitions in the Permian Basin. The company emphasizes operational excellence, technology innovation, and a disciplined approach to capital allocation. Key initiatives include expanding in the Permian Basin, optimizing complementary assets, and enhancing shareholder returns through increa...
11-05 21:11
Director/PDMR Shareholding
Andrew Smith, President, Trading and Supply at Shell plc, disposed of 33,000 ordinary shares of €0.07 each on October 30, 2026, in Amsterdam at a price of €48.622065 per share, totaling €1,604,528.15.
11-02 09:26
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
NeOnc Technologies Holdings (NASDAQ:NTHI) is advancing a pivotal clinical trial targeting approximately 500 patients across 30 hospitals in three countries to address difficult-to-treat brain cancers. The trial focuses on NEO100, an investigational treatment using intranasal administration to bypass the blood-brain barrier. Encouraging early results include significant radiographic remission in 24% of patients. Additionally, NEO212, another drug ...
10-30 13:10
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
Merit Medical Systems acquired Solo Pace, Inc. for $45 million to expand its Cardiac Therapies platform with Solo Pace's temporary pacing systems, including SOLO PACE CONTROL and FUSION, designed to simplify transcatheter aortic valve replacement (TAVR) procedures and improve efficiency and safety.
10-29 20:03
Shell plc publishes third quarter 2026 press release
Shell reported strong third-quarter 2026 results, with adjusted earnings of $10.8 billion, driven by operational performance amid volatile commodity prices. The company completed the ARC Resources acquisition and announced a $5 billion share buyback program. Key highlights include record refining margins, $21 billion in cash flow, disciplined capital spending, and a strong balance sheet with net debt of $39.7 billion. Shell also secured a final i...
10-29 07:01
ONEOK Announces Higher Third-Quarter 2026 Earnings and Increases 2026 Financial Guidance
ONEOK, Inc. reported higher third-quarter 2026 results, with net income of $1.38 billion and adjusted EBITDA of $2.24 billion, up 6% year-over-year. The company highlighted strong performance across its segments, including a 6% increase in NGL raw feed throughput volumes and a 4% rise in Permian region natural gas volumes processed. ONEOK also announced an increase in its 2026 financial guidance, reflecting strong year-to-date performance and con...
10-27 20:15
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
NeOnc Technologies Holdings (NASDAQ:NTHI) has seen its stock price break above $3, supported by strong trading volume and improving technical indicators, signaling a potential reversal. The company has also reported increased short interest, which could amplify volatility. NeOnc recently announced a Memorandum of Understanding with Abu Dhabi's Department of Health, advancing its brain tumor therapies, and shared positive clinical observations fro...
10-23 17:01
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
NeOnc Technologies Holdings (NASDAQ: NTHI) is set to appear on Fox Business Network's *Health Uncensored with Dr. Drew* this Sunday, October 25, at 5:30 p.m. ET. CEO Amir F. Heshmatpour and founder Thomas Chen, MD, PhD, will discuss the company's investigational brain tumor therapies, particularly NEO100, an intranasal candidate designed to bypass the blood-brain barrier. Recent milestones include a memorandum of understanding with Abu Dhabi’s De...
10-22 13:28
